Efficacy and Safety of Anti-HER2 Targeted Therapy for Metastatic HR-Positive and HER2-Positive Breast Cancer: A Bayesian Network Meta-Analysis

Despite the development of HER2-targeted drugs, achieving favorable outcomes for patients with HR+/HER2+MBC remains challenging. This study utilized Bayesian Network Meta-analysis to compare the efficacy and safety of anti-HER2 combination regimens. The primary analysis focused on progression-free s...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xian-Meng, Qian, Yong-Kang, Chen, Hua-Ling, Hu, Chen-Hua, Chen, Bing-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528081/
https://www.ncbi.nlm.nih.gov/pubmed/37754530
http://dx.doi.org/10.3390/curroncol30090615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528081/
https://www.ncbi.nlm.nih.gov/pubmed/37754530
http://dx.doi.org/10.3390/curroncol30090615

Ejemplares similares